IP Library Granted Patent US 9,862,687
Granted Patent B2
US 9,862,687 · App. 15/160,885 · Granted Jan 9, 2018

Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof

Inventors: Roy Wendell Ware, Jr. (Raleigh, NC); Aaron Leigh Downey (Durham, NC)
Assignee: Chimerix, Inc.
C07D239/47C07F9/65121C07F9/65122C07F9/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,862,687
App. No.
15/160,885
Granted
Jan 9, 2018
Kind
B2
Abstract

The disclosure describes methods of synthesis of phosphonate ester compounds. The methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity and stability. Also disclosed are morphic forms of phosphonate ester compounds.

Claims (31)

1. A method of synthesizing Compound 2,

comprising:

(a) heating a mixture of (S)-trityl glycidyl ether, cytosine, a base, and a suitable organic solvent;

(b) cooling the reaction mixture and quenching with toluene to produce a slurry;

(c) cooling the slurry of step (b), filtering to give a solid and washing the solid with toluene;

(d) slurrying the solid of step (c) in toluene, filtering to give a solid, and washing the solid with an organic solvent;

(e) triturating the solid of step (d) in water/acetone; and

(f) filtering to give a solid filter cake.

2. The method of claim 1 , further comprising washing the solid filter cake of step (f) with acetone and suspending the solid filter cake in acetone.

3. The method of claim 2 , wherein the filter cake suspension in acetone is heated at about 35-45° C., and filtered.

4. The method of claim 3 , further comprising removing the acetone from the suspended filter cake and drying the filter cake in vacuo.

5. The method of claim 1 , comprising repeating steps d-e at least once.

6. The method of claim 5 , wherein steps d-e are repeated twice.

7. The method of claim 1 , wherein the purity of compound 2 is at least 91% (wt/wt).

8. The method of claim 1 , wherein the base in step (a) is a metal carbonate.

9. The method of claim 8 , wherein the base in step (a) is potassium carbonate.

10. The method of claim 1 , wherein the organic solvent of step (a) is N, N-dimethylformamide or tert-amyl alcohol.

11. The method of claim 1 , wherein the organic solvent of step (d) is acetone.

12. The method of claim 1 , wherein the mixture of step (a) is heated to about 60-120° C.

13. The method of claim 1 , wherein the mixture of step (a) is heated for about 4-14 hours.

14. The method of claim 1 , wherein the triturating in water and acetone in step (e) takes place at a temperature of about 17-22° C.

15. A method of synthesizing (S)—N 1 -[(2-hydroxy-3-triphenylmethoxy)propyl] cytosine, comprising:

(a) heating a mixture of (S)-trityl glycidyl ether, cytosine, potassium carbonate, and N, N-dimethylformamide (DMF) at about 85-95° C. for about 9 hours;

(b) cooling the reaction mixture of step (a) to about 66-70° C. and quenching with toluene;

(c) cooling the resulting slurry of step (b) to about −10 to 5° C., filtering and washing with toluene;

(d) slurrying the solids in toluene at about 15-25° C., filtering, and then washing with acetone;

(e) triturating the solids in water and acetone at a ratio of about 1:0.6 (wt/wt) at about 17-22° C., filtering to give a filter cake, and washing with acetone;

(f) suspending the filter cake of step (e) in acetone and heating at about 35-45° C. for about 3 hours, filtering to give a solid, and washing with acetone.

16. The method of claim 15 further comprising repeating steps (d) and (e).

17. The method of claim 15 wherein the solid of step (f) is dried in vacuo at a temperature equal to or less than about 40° C. for about 12 hours.

18. The method of claim 15 wherein the purity of the synthesized compound is equal to or greater than 99% as measured by HPLC.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 29, 2026
From: OHA AGENCY LLC, IN ITS CAPACITY AS ADMINISTRATIVE AGENT
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 074509/0516 →
SECURITY INTEREST Recorded Apr 16, 2026
From: EMERGENT BIOSOLUTIONS INC.; EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT TRAVEL HEALTH INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 074389/0054 →
SECURITY INTEREST Recorded Sep 30, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS INC.; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC; EMERGENT TRAVEL HEALTH INC.; EMERGENT BIOSOLUTIONS CANADA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 068746/0698 →
WELLS FARGO BANK, NATIONAL ASSOCIATION Recorded Sep 3, 2024
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 068828/0488 →
NOTICE OF GRANT OF SECURITY INTEREST IN U.S. PATENTS Recorded Sep 3, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS CANADA INC.; EMERGENT BIOSOLUTIONS INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT TRAVEL HEALTH INC.
To: OHA AGENCY LLC
Reel/Frame 068828/0233 →
SECURITY INTEREST Recorded May 18, 2023
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 063689/0954 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE: EMERGENT BIODEFENSE OPERATIONS LANSING LLC 3500 MARTIN LUTHER KING JR. BLVD, LANSING, MICHIGAN 48906 PREVIOUSLY RECORDED AT REEL: 061720 FRAME: 0982. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 4, 2022
From: CHIMERIX, INC.
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 062054/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2022
From: CHIMERIX, INC.
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 061720/0982 →
LICENSE Recorded Oct 29, 2019
From: CHIMERIX, INC.
To: SYMBIO PHARMACEUTICALS LIMITED
Reel/Frame 050864/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2016
From: WARE, ROY WENDELL, JR.; DOWNEY, AARON LEIGH
To: CHIMERIX, INC.
Reel/Frame 038661/0874 →
Continuity (4)
Division 14604334 · Jan 23, 2015
Continuation 14512335 · Oct 10, 2014
Provisional Application 61904857 · Nov 15, 2013
Related Publication 20160264531A1 · Sep 15, 2016